Moderna rises after FDA advisers back flu vaccine
18/06/2026 20:22
BUZZ-Moderna rises after FDA advisers back flu vaccine ** Shares of vaccine maker Moderna MRNA.O rise 4.1% to $64.26
** U.S. FDA advisers unanimously back approval of MRNA's flu vaccine, mFlusiva, for adults aged 50 and older
** All nine panel members vote in favor, saying the shot's benefits outweigh its risks in adults aged 50-64 as well as those aged 65 and above
** Under former FDA Commissioner Marty Makary, the health regulator had rejected Moderna's initial application for the shot before reversing course
** Including session's move, MRNA up 118.1% YTD
(Reporting by Kunal Das in Bengaluru)